The overall aim is to remove diclofenac and other untested veterinary drugs from veterinary use and the environment.
In India the vulture advocacy programme was initiated in 2004 within the Bombay Natural History Society (BNHS) with Royal Society for the Protection of Birds (RSPB) support. Ms Janki Teli is the vulture advocacy officer, building on groundwork by Dr Nita Shah. Work in Nepal has been led by Bird Conservation Nepal (BCN), where Mohan Chandra is building on work by Anand Chaudhary, and in Pakistan, Uzma Khan continues to oversee advocacy efforts there for WWF Pakistan. Meanwhile continued vigilance on diclofenac use is being undertaken across other South and South East Asian countries by others including WCS and the Bangladesh Bird Club. Respective Governments and how receptive they are to the importance of conserving vultures are in each case the crucial elements for taking the necessary steps needed. Below are listed some of the key steps and progress to date:
An international meeting organised by MoEF in Delhi with key BNHS and RSPB input and support. This formalised recommendations on the priority to ban diclofenac and for vulture conservation breeding centres. This resulted in an Indian Government Vulture Action Plan being produced in April 2006. March 2005 National Board of Wildlife (India), chaired by Prime Minister Dr. Manmohan Singh, gave a directive for veterinary diclofenac ban within a stipulated time frame.
SAVE Programme Manager,
International Species Recovery,
RSPB, The Lodge,
SG19 2DL, UK
+44 (0) 1767 680 551
Charity Number: 207076
Copyright RSPB 2016